BlackRock
IGC icon

BlackRock’s IGC Pharma IGC Stock Holding History

BlackRock’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Hold
703,798
– – ﹤0.01% 4823
2026
Q1 		$185K Hold
703,798
– – ﹤0.01% 4790
2025
Q4 		$198K Hold
703,798
– – ﹤0.01% 4727
2025
Q3 		$293K Hold
703,798
– – ﹤0.01% 4598
2025
Q2 		$215K Hold
703,798
– – ﹤0.01% 4656
2025
Q1 		$201K Hold
703,798
– – ﹤0.01% 4600
2024
Q4 		$236K Hold
703,798
– – ﹤0.01% 4588
2024
Q3 		$300K Hold
703,798
– – ﹤0.01% 4442
2024
Q2 		$305K Sell
703,798
-11,642
-2% -$5.79K ﹤0.01% 4455
2024
Q1 		$286K Sell
715,440
-2,444
-0.3% -$759 ﹤0.01% 4516
2023
Q4 		$201K Hold
717,884
– – ﹤0.01% 4634
2023
Q3 		$258K Sell
717,884
-37,902
-5% -$13.6K ﹤0.01% 4612
2023
Q2 		$236K Sell
755,786
-76
-0% -$25 ﹤0.01% 4691
2023
Q1 		$257K Hold
755,862
– – ﹤0.01% 4708
2022
Q4 		$240K Buy
755,862
+11,642
+2% +$4.75K ﹤0.01% 4800
2022
Q3 		$321K Buy
744,220
+56
+0% +$30 ﹤0.01% 4848
2022
Q2 		$394K Sell
744,164
-114,622
-13% -$72.3K ﹤0.01% 4849
2022
Q1 		$815K Sell
858,786
-2,428
-0.3% -$2.36K ﹤0.01% 4733
2021
Q4 		$842K Buy
861,214
+18,931
+2% +$25.4K ﹤0.01% 4723
2021
Q3 		$1.25M Sell
842,283
-972
-0.1% -$1.57K ﹤0.01% 4500
2021
Q2 		$1.38M Sell
843,255
-67,711
-7% -$103K ﹤0.01% 4418
2021
Q1 		$1.63M Buy
910,966
+1,744
+0.2% +$3.17K ﹤0.01% 4356
2020
Q4 		$1.42M Buy
909,222
+881,396
+3,168% +$1.3M ﹤0.01% 4131
2020
Q3 		$29K Buy
27,826
+12
+0% +$12 ﹤0.01% 4668
2020
Q2 		$17K Sell
27,814
-66,730
-71% -$36.2K ﹤0.01% 4722
2020
Q1 		$47K Buy
94,544
+60,290
+176% +$33.4K ﹤0.01% 4485
2019
Q4 		$22K Buy
34,254
+26,774
+358% +$21.9K ﹤0.01% 4642
2019
Q3 		$7K Buy
+7,480
New +$9K ﹤0.01% 4750

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock's IGC Position: Q2 2026 in Review

BlackRock held its IGC Pharma (IGC) position steady in Q2 2026 at 703,798 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #4823.

BlackRock first reported a position in IGC in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.63M in Q1 2021. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • BlackRock held 703,798 shares of IGC Pharma worth $191K as of Q2 2026.
  • BlackRock left its IGC Pharma share count unchanged in Q2 2026.
  • IGC Pharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4823 holding.
  • BlackRock first reported a position in IGC Pharma in Q3 2019 and has held it in 28 quarters since.
  • BlackRock's IGC Pharma position peaked at $1.63M in Q1 2021.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.